English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 1 August 2018, 18:35 HKT/SGT
Share:
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

Hangzhou and Shaoxing, China , Aug 1, 2018 - (ACN Newswire) - Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new drug application (NDA). Ravidasvir in combination with Ganovo (RDV/DNV Regimen) is the first all-oral interferon-free HCV regimen developed by a domestic company in China. Phase II/III clinical trial has shown that RDV/DNV Regimen demonstrated a cure rate of 99 % ( SVR12) with a short treatment duration of 12 weeks in genotype 1 patients. In patients with baseline NS5A resistance mutations, RDV/DNV Regimen demonstrated a cure rate of 100% (SVR12).

"Ascletis was successfully listed this morning on Hong Kong Exchange as the first ever pre-revenue biotech. The NDA for our all-oral HCV regimen was accepted by CFDA in the afternoon." Jinzi J. Wu, Ph.D., Ascletis' founder, President and CEO, commented, "Two significant accomplishments on the same day reflect our unremitting effort to provide affordable and effective HCV cures to the patients and to fulfill our commitment to the investors."

Ganovo Regimen, Ascletis' first breakthrough HCV regimen, was approved on June 8 and launched on June 27, 19 days after the approval. The acceptance of the NDA for its all-oral HCV regimen enables Ascletis soon to provide two HCV treatment options for Chinese patients, strengthening its leading position in China's HCV field.


Topic: Press release summary
Sectors: Daily Finance, Daily News, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Business Travel Startup Travelstop Strengthens Its Presence in Asia, Launches in Seven Markets  
Jan 22, 2019 10:00 HKT/SGT
Murata Manufacturing Conducts Field Trial Utilizing Soil Monitoring System to Visualize the Condition of Agricultural Land  
Jan 22, 2019 10:00 HKT/SGT
[email protected] Succeeds In Developing R2M2 - Enhances Efficiency of Repairing Old Buildings  
Jan 21, 2019 20:50 HKT/SGT
HKTDC Education & Careers Expo Opens on Thursday  
Jan 21, 2019 19:00 HKT/SGT
Kinetic Mines Issued Positive Profit Alert; Expected 40% Growth in the Net Profit for 2018   
Jan 21, 2019 16:54 HKT/SGT
SDK's 3.5-inch Media Now Used in World's-Largest-Capacity 16TB HDD  
Jan 21, 2019 13:00 HKT/SGT
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer  
Jan 21, 2019 13:00 HKT/SGT
Hong Kong ESG Reporting Awards 2019 Announces Partnerships with CUHK Jockey Club Museum of Climate Change and SDSN Hong Kong  
Jan 21, 2019 12:00 HKT/SGT
MHPS Opens "Remote Monitoring Center" in the Main Office of Its Nagasaki Works  
Jan 21, 2019 10:40 HKT/SGT
China Resources Power and Black Spade Capital sign a strategic joint venture cooperation agreement; teaming up to create an environmentally friendly world  
Jan 21, 2019 09:04 HKT/SGT
More Press release >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: